In the May-June 2008 issue of The Spine Journal, a clinical study was published involving 323 patients who each had vertebrae fused in their necks. Post-surgery, approximately half of the participants engaged in PEMF therapy while the other half served as a control. The patients’ statuses were evaluated at one, two, three, six, and twelve month intervals. Notably, the researchers found that the PEMF group had an 83.6 percent successful fusion rate at six months’ post-op compared to the control group’s 68.6 percent. Similar results were discovered at the 12 month interval.
The results suggest that PEMF therapy aided in the post-op healing process and bone growth.
In Bio-Electromagnetics, one study looked at 11 different trials involving PEMF to determine its level of therapeutic effect. Some of these studies involved PEMF’s effects on osteoarthritis, fibromyalgia, or pain perception; while the rest focused on how PEMF positively impacted skin ulcers, fatigue related to multiple sclerosis, heart rate variability, and overall well-being.
PEMF has also shown positive effects with Alzheimer’s disease, Lou Gehrig’s, heart disease, depression, diabetes, endometriosis, epilepsy, headaches, glaucoma, hepatitis, kidney problems, lung disease, lupus, multiple sclerosis, pancreatitis, Parkinson’s, sleep disorders, spinal cord injury, stroke, Tourette’s, ulcers, urinary problems, and more.